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Abstract  
Chronic pain is a major source of suffering. It interferes with daily functioning, and often is 
accompanied by distress. Yet, in the International Classification of Diseases (ICD), chronic pain 
diagnoses are not represented systematically. The lack of appropriate codes renders accurate 
epidemiological investigations difficult and impedes health policy decisions regarding chronic 
pain. This hinders adequate financing of treatments for chronic pain patients, limiting access 
to multimodal care. In cooperation with the WHO, an IASP Working Group has developed a 
classification system that is applicable in a wide range of contexts, including pain medicine, 
primary care, and low-resource environments. Chronic pain is defined as pain that persists or 
recurs for more than three months. In chronic pain syndromes, pain can be the sole or a 
leading complaint and requires special treatment and care. In conditions such as fibromyalgia 
or nonspecific low back pain, chronic pain may be conceived as a disease in its own right; in 
our proposal, we call this subgroup ‘chronic primary pain’. In six other subgroups, pain is 
secondary to an underlying disease: chronic cancer-related pain, chronic neuropathic pain, 
chronic secondary visceral pain, chronic posttraumatic and postsurgical pain, chronic 
secondary headache and orofacial pain, and chronic secondary musculoskeletal pain. These 
conditions are summarized as ‘chronic secondary pain’ where pain may at least initially be 
conceived as a symptom. Implementation of these codes in the upcoming 11th edition of ICD 
will lead to improved classification and diagnostic coding, thereby advancing the recognition 
of chronic pain as a health condition in its own right. 
 
Keywords: Classification; ICD-11; Chronic Pain; Symptom; Disease; Chronic Primary Pain; 
Chronic Secondary Pain; Functioning; Diagnoses; Coding;   
Main manuscript
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
1. Introduction 
Pain is one of the most frequent causes for patients to seek medical.27 While mortality rates 
are highest for cardiac infarction and stroke, infectious diseases, cancers and diabetes, chronic 
pain is a leading source of human suffering and disability (Goldberg and McGee 2011).17 Pain 
itself and many diseases associated with chronic pain are not immediately life threatening; 
people continue to live with their pain and hence these conditions are common in both 
developed and developing countries.8,11 The Global Burden of Disease Study 2013 evaluated 
‘years lived with disability’ (YLDs: the prevalence multiplied by a disability-weighting factor) 
for a broad range of diseases and injuries in 188 countries.33 The single greatest cause of YLDs 
around the world was chronic low back pain, followed by major depressive disorder. Other 
frequent causes of YLDs include chronic neck pain, migraine, osteoarthritis, other 
musculoskeletal disorders, and medication overuse headache. Chronic back pain and chronic 
neck pain featured in the top 10 causes of YLDs in every country examined.  
Yet, in the International Classification of Diseases (ICD), chronic pain diagnoses are not 
represented systematically.14,34 In many modern health care systems, referral for specific 
treatment such as multimodal pain management is dependent upon suitable ICD codes as 
indications. The lack of appropriate codes contributes to the paucity of clearly defined 
treatment pathways for patients with chronic pain. Some pain specialists have argued for 
recognition of chronic pain as a disease in its own right (for a review see 32), while others have 
argued against this. Recognition of migraine as a primary headache disorder has been a crucial 
step towards including the International Headache Classification of the International 
Headache Society into ICD.20 Similarly, conditions such as fibromyalgia or complex regional 
pain syndrome may qualify for classification as primary pain disorders in ICD. On the other 
hand, chronic pain may be secondary to osteoarthritis or diabetic polyneuropathy, where it 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
may at least initially be considered as a symptom. In either case, chronic pain is a long-term 
condition that requires special treatment and care.  
Pain management should be guided by some measure of patient reported severity of this long-
term condition. In acute pain management, a level of ‘no more than mild pain’ was established 
as treatment goal.28 Comparison of the epidemiology of 'any', 'significant' and 'severe' chronic 
pain indicated progressively more marked adverse associations with employment status, 
interference with daily activities and general health.39 Thus, a future classification of chronic 
pain should also include an option to code pain severity, which refers not just to pain intensity, 
but also to distress and disability.  
A systematic classification of chronic pain was developed by a task force of the International 
Association for the Study of Pain (IASP).42 This classification distinguishes chronic primary and 
chronic secondary pain syndromes, integrates existing pain diagnoses including headaches, 
provides precise definitions and further characteristic features of the respective diagnoses 
according to the content model of the WHO for ICD-11, including the severity of pain, its 
temporal course and evidence for psychological and social factors. It also aims to harmonize 
definitions and descriptions of chronic pain syndromes, and to use similar classification 
rationales as far as possible. These pain diagnoses have been implemented in the 11th version 
of ICD that was released by WHO in June 2018.  
 
2. Methods 
The IASP, an NGO in official relationship with the WHO, contacted the WHO in 2012 with 
respect to developing a new and pragmatic classification of chronic pain for the upcoming 11th 
revision of the ICD. The goal was to create a classification system that is applicable in clinical 
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settings for specialized pain management as well as in primary care. A Task Force for the 
Classification of Chronic Pain was formed by recruiting pain experts from around the globe 
http://www.iasp-pain.org/Advocacy/icd.aspx?ItemNumber=5234&navItemNumber=5236], 
soliciting recommendations from IASP special interest groups and topical advisory groups of 
other ICD-11 sections. The co-chairs of the Task Force (WR and RDT) were in regular contact 
with WHO representatives. The overall structure of the chronic pain classification was 
developed by group consensus at the first face-to-face meeting and by plenary phone 
conferences. Subsequently, the subtopics were assigned to seven smaller author teams 
moderated by AB; overlaps between subtopics (e.g. chronic neuropathic pain after cancer 
treatment) were resolved via e-mail and phone conferences and definitions established by 
consensus among the teams concerned, and guidelines for classification in overlapping fields 
were specified.  
The ICD-11 development process requires the generation of content models for each 
diagnostic entity, which contain definitions, diagnostic criteria and synonyms as well as state 
of the art scientific information about the respective entity. The content models were 
developed by the seven author teams, and were then entered as children of the appropriate 
parent entities via the WHO proposal platform. Preliminary versions of the classification were 
published (Treede et al. 2015),42 presented at international conferences (World Congress on 
Pain 2016, European Pain Congress 2017) and were open to public comment via the IASP 
website and the WHO proposal platform. An early version of the classification underwent pilot 
ecological field testing in five countries in 2016.3 The prefinal version was further subjected to 
the official international field testing of the WHO via the IASP website.  
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3. Results 
Chronic pain was defined previously as pain that persists past normal healing time7 and hence 
lacks the acute warning function of physiological nociception. The concept of persistence 
beyond normal healing may apply to pain after surgery and the concept of lack of warning 
function to migraine headaches; but these concepts are difficult to verify in other conditions 
such as chronic musculoskeletal or neuropathic pains. Hence, a purely temporal criterion was 
chosen: chronic pain is pain that lasts or recurs for longer than 3 months.42  
The chronic pain definition was cast into the format of the ‘content models’ as required by 
WHO for ICD-11 and was entered into what is called the ‘foundation layer of ICD-11’. The 
foundation layer is the set of all entities represented in the ICD-11, which is continually 
updated and expanded, and where each is assigned a unique identifier (chronic pain: 
http://id.who.int/icd/entity/1581976053). Chronic pain is the ‘parent code’ for seven other 
codes that comprise the most common clinically relevant groups of chronic pain conditions 
(Figure 1): (i) chronic primary pain; (ii) chronic cancer-related pain; (iii) chronic postsurgical 
and posttraumatic pain; (iv) chronic neuropathic pain; (v) chronic secondary headache and 
orofacial pain; (vi) chronic secondary visceral pain; (vii) chronic secondary musculoskeletal 
pain.  
------------ 
Insert Figure 1 about here 
------------ 
There is some overlap between these groups of chronic pain conditions (e.g. neuropathic pain 
caused by cancer or its treatment) and between the pain codes and other existing codes in 
ICD-11 (e.g. chronic headaches). The ICD-11 solves the problem of entities that belong to 
several fields (e.g. stroke as both a cardiovascular and a neurological disorder) by so-called 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
‘multiple parenting’. Multiple parenting allows that one definition (the child) may be accessed 
from more than one higher level category (parent). This feature allows more flexibility than in 
previous versions of ICD; for an example see Figure 2.  
------------ 
Insert Figure 2 about here 
------------ 
So-called ’linearizations’ are subsets of the foundation layer that are used for statistical and 
coding purposes. The most important linearization is the ’Mortality and Morbidity 
Linearization’. The new ICD category for ’Chronic Pain’ and its seven sub-categories are part 
of this linearization, where they are listed in the chapter that describes ‘certain symptoms, for 
which supplementary information is provided, that represent important problems in medical 
care in their own right’ (Chapter 21). A ‘frozen version’ of the Mortality and Morbidity 
Linearization for quality control through field testing was made available in April 2017 and was 
updated in April 2018; the codes in linearizations may change over time as ICD-11 evolves and 
is maintained by the WHO (Chronic pain was MJ60 in 2017 and MG30 in 2018 frozen versions). 
A ‘frozen version for implementation’ has been published on June 18, 2018, and is scheduled 
for voting by the World Health Assembly in May 2019. Following endorsement, countries 
around the world are expected to report their health statistics using ICD-11 from 2022 
onward.  
 
3.1 Chronic primary pain syndromes 
Chronic primary pain is defined as pain in one or more anatomic regions that persists or recurs 
for longer than 3 months and is associated with significant emotional distress or functional 
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disability (interference with activities of daily life and participation in social roles) and that 
cannot be better explained by another chronic pain condition.29 This is a new 
phenomenological definition, which applies to chronic pain syndromes that are best 
conceived as health conditions in their own right.32 Examples include chronic widespread pain, 
complex regional pain syndromes, and irritable bowel syndrome. Chronic primary headaches 
are cross-referenced in this section making use of the ‘multiple parenting’ option of ICD-11, 
which means that chronic migraine is listed in both the headache section and the chronic pain 
section. The term ‘chronic primary pain’ may sound unusual, but is consistent with language 
used in other parts of ICD-11. The recently proposed definition of ‘nociplastic pain’ may 
describe some of the underlying mechanisms.25 
 
3.2. Chronic secondary pain syndromes 
Chronic secondary pain syndromes are linked to other diseases as the underlying cause, for 
which pain may initially be regarded as a symptom. The proposed new ICD-11 codes become 
relevant as a co-diagnosis, when this symptom requires specific care for the patient. This 
marks the stage when the chronic pain becomes a problem in its own right. In many cases, the 
chronic pain may continue beyond successful treatment of the initial cause; in such cases the 
pain diagnosis will remain, even after the diagnosis of the underlying disease is no longer 
relevant. We expect that this new coding will facilitate treatment pathways for patients with 
these painful conditions by recognizing the chronic pain problem early in the course of the 
disease. This is also important if the underlying disease is painful in only some of the patients; 
disease diagnosis alone does not identify these patients without the co-diagnosis of chronic 
pain.  
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3.2.1. Chronic cancer-related pain  
Chronic cancer-related pain is defined as pain caused by the cancer itself (by the primary 
tumor or by metastases) or by its treatment (surgery, chemotherapy, radiotherapy).4 Pain is a 
frequent and debilitating accompaniment of cancer and its treatment.10 It becomes more and 
more apparent that chronic pain syndromes are prevalent in long-term survivors of cancer 
and that these chronic secondary pain syndromes include neuropathic and musculoskeletal 
pains.15 Chronic pain caused by the cancer or by chemotherapy or radiation therapy is coded 
in this section. Pain that is caused by surgical cancer treatment is coded in the section of 
chronic postsurgical pain.  
 
3.2.2. Chronic postsurgical and posttraumatic pain 
Whether or not pain persists past normal healing time7 is operationalized most naturally for 
chronic pain after surgery or other trauma, where the initiating events and normal healing 
times are known. To be consistent with the definition of the parent entity ‘chronic pain’, the 
temporal criterion of three months is also used as cutoff here, even though aspects of 
chronicity may be detectable earlier.26 Diagnostic entities within this category are divided 
according to the initiating event being either surgical or nonsurgical trauma.37 Chronic 
postsurgical pain is a prime candidate for prevention programs to be combined with the usual 
preparation of a patient for surgery. Chronic posttraumatic pain is a major problem in 
rehabilitation and return-to-work programs. In both cases, pain often is neuropathic in nature 
(on average 30% of cases with a range from 6 to 54% and more).18 In such cases ‘chronic 
peripheral neuropathic pain’ may be given as a codiagnosis.  
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3.2.3. Chronic neuropathic pain  
Neuropathic pain is defined as pain caused by a lesion or disease of the somatosensory 
nervous system.22,41 This pain is typically perceived within the innervation territory that is 
somatotopically represented within the lesioned nervous system structure (projected pain). 
Neuropathic pain may be spontaneous or evoked by sensory stimuli (hyperalgesia, allodynia). 
This category is divided into chronic peripheral or chronic central neuropathic pain.36 
Algorithms for grading the diagnostic certainty have been published.13,41 The diagnosis of 
neuropathic pain requires a history of nervous system injury, for example, by a stroke, nerve 
trauma or diabetic neuropathy, and a neuro-anatomically plausible distribution of the pain. 
Negative (loss of sensory function) or positive sensory signs (pain, paresthesia) must be 
compatible with the innervation territory of the lesioned nervous structure. For the 
identification of definite neuropathic pain, it is necessary to additionally demonstrate the 
lesion or disease involving the nervous system, for example, by imaging, biopsy, or 
neurophysiological tests. Questionnaires may be useful as screening tools to support the 
clinical hypothesis of neuropathic pain but are not diagnostic.1  
 
3.2.4. Chronic secondary headache or orofacial pain  
This section is largely cross-referenced to the headache classification of the International 
Headache Society (IHS) that is implemented in full in the chapter on neurology.20 The IHS 
classification differentiates between primary (idiopathic) headaches, secondary 
(symptomatic) headaches and orofacial pains including cranial neuralgias. Chronic headache 
and orofacial pain is defined as headaches or orofacial pains that occur for more than two 
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hours per day on at least 50% of the days during at least 3 months. Only chronic secondary 
headaches and chronic orofacial pains are included here;6 chronic primary headaches are 
listed under chronic primary pain syndromes. The subdivisions of chronic orofacial pain are 
more elaborate than in the IHS classification, thanks to contributions from the IASP SIG on 
orofacial pain and include chronic dental pains and temporomandibular disorders.5  
 
3.2.5. Chronic secondary visceral pain  
Chronic secondary visceral pain is defined as persistent or recurrent pain that originates from 
internal organs of the head/neck region and the thoracic, abdominal and pelvic cavities 
(Schwartz and Gebhart 2014).38 The pain is usually perceived in somatic tissues of the body 
wall (skin, subcutis, muscle) in areas that receive the same sensory innervation as the internal 
organ at the origin of the symptom (referred visceral pain) (Giamberardino et al. 2006).16 
Diagnostic entities within this category are subdivided according to the major underlying 
mechanisms, i.e. mechanical factors (e.g., traction, obstruction), vascular mechanisms 
(ischemia, thrombosis), or persistent inflammation.2 Pain due to cancer or metastasis in 
internal organs is coded in the chapter chronic cancer-related pain, whereas pain due to 
functional or unexplained mechanisms is listed under chronic primary pain. 
 
3.2.6 Chronic secondary musculoskeletal pain  
Chronic secondary musculoskeletal pain is defined as persistent or recurrent pain that arises 
as part of a disease process directly affecting bone(s), joint(s), muscle(s) or related soft 
tissue(s).31 Pain may be spontaneous or movement-induced. This category is limited to 
nociceptive pain and does not include pain that may be perceived in musculoskeletal tissues 
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but does not arise therefrom, such as the pain of compression neuropathy or somatic referred 
pain. Diagnostic entities within this category are subdivided according to the major underlying 
mechanisms, i.e. persistent inflammation of infectious, auto-immune or metabolic etiology 
(e.g. rheumatoid arthritis), structural changes affecting bones, joints, tendons or muscles (e.g. 
symptomatic osteoarthrosis) or chronic musculoskeletal pain secondary to diseases of the 
motor nervous system (e.g. spasticity after spinal cord injury or rigidity in Parkinson’s disease). 
Well-described apparent musculoskeletal conditions for which the causes are incompletely 
understood, such as non-specific back pain or chronic widespread pain, are included in the 
section on chronic primary pain.  
 
3.3 Severity and other extension codes in ICD-11 
Optional specifiers (called ‘extension codes’ in WHO terminology) are available for all chronic 
pain diagnoses and allow recording pain severity, its temporal course and evidence of 
psychological and social factors. The severity of chronic pain is proposed to be determined as 
a compound measure of pain intensity, and pain-related distress and task interference. Pain 
intensity denotes the strength of the subjective pain experience (‘how much does it hurt?’). 
Pain-related distress is the multifactorial unpleasant emotional experience of a psychological 
(cognitive, behavioral, emotional), social or spiritual nature due to the persistent or recurrent 
experience of pain (‘how distressed are you by the pain?’).21 Pain-related interference 
describes how much the pain interferes with daily activities and participation (‘how much does 
the pain interfere with your life?’). Each of the severity determinants (intensity, pain-related 
distress, interference) is rated by the patient on a numerical rating scale from 0 - 10 and then 
transformed into WHO severity stages of ‘mild’, ‘moderate’ and severe’ (see Box 1).  Temporal 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
characteristics can be coded as continuous pain, episodic recurrent pain and continuous pain 
with pain attacks.  
The presence of significant psychological and social factors can also be documented with an 
extension code. Psychological factors in this sense are cognitive (such as catastrophizing or 
worry and rumination;12,40), behavioral (such as avoidance or endurance;19,44), emotional 
(such as fear or anger;35,43). Social factors refer to the impact of chronic pain on the 
relationship with others and vice versa.9,23 This extension code should be used when 
psychological and social factors are judged to contribute to the onset, the maintenance or 
exacerbations of pain or are regarded as relevant consequences of the pain. Assigning this 
extension code does not require a judgement regarding causal priorities or etiological 
contributions. Since all chronic pain is regarded as a multifactorial, biopsychosocial 
phenomenon, this extension code is available for all chronic pain diagnoses and is not limited 
to the chronic primary pain syndromes.  
ICD-11 will be coordinated within the WHO Family of International Classifications that also 
includes the International Code of Functioning (ICF) and the International Code of Health 
Interventions (ICHI). Each ICD-11 code will refer to the relevant section of ICF as ‘functional 
properties# of the ICD code. A harmonization with ICF is particularly relevant for chronic pain 
conditions, because both systems address pain and pain-associated disability. The ICF was 
developed by the International Society for Physical and Rehabilitation Medicine (ISPRM) with 
the WHO. A draft of the functioning properties for chronic pain on the basis of the ICF domains 
was developed jointly by IASP and ISPRM.30  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
 
4. Discussion 
The classification system for chronic pain conditions submitted by IASP to WHO is compatible 
with ICD-principles and aims to improve pain research, health policy decisions, and patient 
care. The temporal cut-off of three months for defining chronic pain has the advantage that 
clinicians, at a reasonable point in time, will be alerted to the possibility that pain may be the 
leading or sole medical problem of a given patient. This clearly operationalized and easily 
measurable criterion will help to use uniform criteria in healthcare statistics, clinical trials, 
publications, and medical textbooks. The question whether pain can become chronic at an 
earlier stage is a research question that can also be addressed by contrasting patient histories 
with this definition.  
In the field of headache, precise and operationalized criteria for diagnosis (e.g. a strict 
temporal criterion for migraine) have greatly facilitated research in all areas ranging from basic 
to epidemiological science, which in turn informed the refinement of diagnostic criteria at a 
later stage. One of the aims of the new classification of chronic pain is to improve reporting 
for health statistics and research by clearly operationalized criteria. The organizing principle is 
the same as that used throughout ICD: give first priority to pain etiology (primary pain 
syndromes, cancer-related pain, postsurgical and posttraumatic pain), followed by underlying 
pathophysiological mechanisms (neuropathic pain), and finally body site or affected organ 
system (headache and orofacial pains, visceral pain, musculoskeletal pain).  
Integrating existing diagnoses into this multilayered classification was greatly facilitated by the 
principle of ‘multiple parenting’: it allows the same diagnosis to be referenced in more than 
one category. In this regard, ICD-11 transcends the discipline-specific structure of previous 
versions. It allows different angles from which to approach a diagnosis: A cancer-specialist will 
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be able to look up chronic neuropathic chemotherapy-induced pain among the cancer-related 
pain diagnoses, whereas a neurologist will be able to find exactly the same diagnosis from the 
perspective of chronic neuropathic pain. Especially, for a phenomenon such as chronic pain, 
which – by its very nature – may be part of many different conditions and important to many 
medical specialties, this is a great advancement that facilitated inclusion of the current 
classification of chronic pain into ICD-11 itself.  
Chronic pain may be a symptom of an underlying chronic condition, but it frequently outlasts 
the normal healing process and often no other underlying disease can be identified. The 
proposed classification of chronic pain distinguishes between chronic primary pain syndromes 
(long-term conditions in their own right) and chronic secondary pain syndromes (symptoms 
of another non-pain problem). If the chronic pain condition persists, clinicians should continue 
to use a diagnosis of chronic secondary pain even after the causing medical condition has been 
treated successfully or remitted. After longer periods of obvious dissociation between the 
medical causes and chronic pain, and with clear evidence for other factors determining the 
chronic pain condition, a change of the chronic pain diagnosis (e.g., to chronic primary pain, 
or to another chronic secondary pain diagnosis) should be considered.   
With the introduction of chronic primary pain as a new diagnostic entity, the classification 
recognizes conditions that affect a broad group of pain patients who are not adequately 
represented in categories defined strictly according to either somatic or psychological etiology 
(Rief et al. 2008). Due to the success of the behavioral neurosciences, even mental disorders 
can nowadays no longer be considered purely non-somatic. Of note, all chronic pain, including 
chronic primary pain, will be coded outside the realm of psychiatric diagnosis: This accords 
more with the current scientific understanding of chronic pain and often aligns better with 
patients’ own views. In addition, it will help avoid stigma in many cultures.24  
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All clinically relevant chronic pain is conceptualized within the biopsychosocial model. The 
seven major categories of chronic pain represent a compromise between comprehensiveness 
and practical applicability of the classification system. Several clinically important conditions 
that were neglected or inadequately represented in previous ICD revisions are now included 
as diagnoses, e.g. chronic cancer-related pain, chronic postsurgical pain or chronic 
neuropathic pain. Etiological factors, temporal factors, pain severity and functional properties 
are reflected. Assessment of pain intensity and severity should become part of all routine 
medical examinations. Underlying causes and mechanisms should then be identified and lead 
to a personalized pain management plan. Joint efforts by IASP and WHO have resulted in the 
WHO analgesic ladder for treatment of cancer pain in 1986. Now is the time for a similar 
coordinated effort to promote improved diagnostic classification and multimodal 
management approaches for pain around the world.  
 
5. Conclusion 
This is the first systematic classification of chronic pain that is also part of the ICD. We hope 
that this classification strengthens the representation of chronic pain conditions in clinical 
practice and research. The introduction of appropriate codes for chronic primary and 
secondary pain syndromes is expected to promote access to multimodal care for all chronic 
pain patients. It will facilitate accurate epidemiological investigations and health policy 
decisions regarding chronic pain, including adequate financing of treatments.  
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Box 1: Specifiers or ‘extension codes’ in ICD-11 
Pain intensity may be assessed verbally or on a numerical or visual rating scale. For the severity 
coding the patient should be asked to rate the average pain intensity for the last week on an 
11-point NRS rating scale (ranging from from 0 ‘no pain’ to 10 ‘worst pain imaginable’) or a 
100 mm VAS scale: 
mild pain   (NRS: 1-3; VAS: <31mm) 
moderate pain  (NRS: 4-6; VAS: 31-54mm) 
severe pain   (NRS: 7-10; VAS: 55-100mm)  
 
Pain-related distress may be assessed by asking the person to rate the pain-related distress 
they experienced in the last week (multifactorial unpleasant emotional experience of a 
cognitive, behavioral, emotional, social or spiritual nature due to the persistent or recurrent 
experience of paint) on an 11-point numerical rating scale or a VAS scale from ‘no pain-related 
distress’ to ‘extreme pain-related distress’ (‘Distress Thermometer’). 
mild distress   (NRS: 1-3; VAS: <31mm) 
moderate distress  (NRS: 4-6; VAS: 31-54mm) 
severe distress  (NRS: 7-10; VAS: 55-100mm) 
 
Pain-related interference last week as rated by the patient on an 11-point numerical rating 
scale (NRS: from 0 ‘no interference’ to 10 ‘unable to carry on activities’) or Visual Analog Scale 
(VAS: 0mm ‘no interference’ to 100mm ‘unable to carry on activities’).  
Code 0: no interference 
Code 1: mild interference  (NRS: 1-3; VAS: <31mm) 
Code 2: moderate interference (NRS: 4-6; VAS: 31-54mm) 
Code 3: severe interference  (NRS: 7-10; VAS: 55-100mm) 
 
Overall severity combines the ratings of intensity, distress and disability using a three-digit 
code: Example: A patient with a moderate pain intensity, severe distress and mild disability 
will receive the code ‘231’. The severity code is optional. 
Other extension codes are temporal characteristics (continuous, episodic recurrent, 
continuous pain with attacks) and psychosocial cofactors (cognitive, behavioral, emotional, 
social).  
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Figure Legends:  
 
Fig. 1: Structure of the IASP Classification of Chronic Pain 
 
Notes to Figure 1 
In chronic primary pain syndromes (left) pain can be conceived as a disease, while in chronic 
secondary pain syndromes (right) pain initially manifests itself as a symptom of another 
disease such as breast cancer, a work accident, diabetic neuropathy, chronic caries, 
inflammatory bowel disease or rheumatoid arthritis. Differential diagnosis between primary 
and secondary pain conditions may sometimes be challenging (arrows), but in either case the 
patient’s pain needs special care when it is moderate or severe. After spontaneous healing or 
successful management of the underlying disease, chronic pain may sometimes continue and 
hence the chronic secondary pain diagnoses may remain and continue to guide treatment as 
well as health care statistics.  
 
 
Fig. 2: Multiple parenting concept of WHO for ICD-11 
 
Notes to Figure 2 
In contrast to the strictly linear structure of all previous versions of ICD, ICD-11 allows for any 
given disease (‘child’) to belong to more than one section (‘parent’). This is called ‘multiple 
parenting’. ‘Chronic painful chemotherapy-induced polyneuropathy’ is illustrated here as one 
example.  
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